Goldman Sachs Group Inc Bio Techne Corp Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,536,138 shares of TECH stock, worth $91.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,536,138

Previous 1,666,237 7.81%

Holding current value

$91.2 Million

Previous $85.7 Million 0.32%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$49.87 - $58.78 $6.49 Million - $7.65 Million	-130,099 Reduced 7.81%	1,536,138 $85.5 Million
Q2 2025 Aug 14, 2025	BUY	$46.66 - $58.38 $28.1 Million - $35.2 Million	602,298 Added 56.61%	1,666,237 $85.7 Million
Q1 2025 May 09, 2025	BUY	$58.47 - $78.75 $6.64 Million - $8.95 Million	113,634 Added 11.96%	1,063,939 $62.4 Million
Q4 2024 Feb 11, 2025	BUY	$66.37 - $78.17 $13.2 Million - $15.6 Million	199,093 Added 26.5%	950,305 $68.5 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $7.64 Million - $8.87 Million	-107,661 Reduced 12.54%	751,212 $60 Million

Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $6.52 Million - $8.83 Million	104,979 Added 13.92%	858,873 $61.5 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $1.29 Million - $1.51 Million	19,557 Added 2.66%	753,894 $53.1 Million
Q4 2023 Feb 13, 2024	BUY	$52.83 - $78.22 $9.58 Million - $14.2 Million	181,376 Added 32.8%	734,337 $56.7 Million
Q3 2023 May 14, 2024	SELL	$67.52 - $89.42 $12.2 Million - $16.2 Million	-181,376 Reduced 24.7%	552,961 $37.6 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $6.93 Million - $9.18 Million	-102,663 Reduced 15.66%	552,961 $37.6 Million
Q2 2023 May 14, 2024	BUY	$73.76 - $85.98 $16.7 Million - $19.4 Million	225,835 Added 52.55%	655,624 $53.5 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $16.7 Million - $19.4 Million	225,835 Added 52.55%	655,624 $53.5 Million
Q1 2023 May 14, 2024	BUY	$71.62 - $86.62 $14 Million - $16.9 Million	194,960 Added 83.02%	429,789 $31.9 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $14 Million - $16.9 Million	194,960 Added 83.02%	429,789 $31.9 Million
Q4 2022 May 14, 2024	BUY	$80.67 - $352.29 $14.6 Million - $63.9 Million	181,492 Added 340.27%	234,829 $19.5 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $14.6 Million - $63.9 Million	181,492 Added 340.27%	234,829 $19.5 Million
Q3 2022 May 14, 2024	SELL	$282.54 - $391.85 $1.32 Million - $1.83 Million	-4,666 Reduced 8.04%	53,337 $15.1 Million
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $1.32 Million - $1.83 Million	-4,666 Reduced 8.04%	53,337 $15.1 Million
Q2 2022 May 14, 2024	SELL	$322.67 - $449.65 $218 Million - $304 Million	-676,334 Reduced 92.1%	58,003 $20.1 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $3.65 Million - $5.09 Million	-11,320 Reduced 16.33%	58,003 $20.1 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $19.9 Million - $27.4 Million	-56,205 Reduced 44.77%	69,323 $30 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $2.3 Million - $2.65 Million	-5,044 Reduced 3.86%	125,528 $64.9 Million
Q3 2021 Nov 10, 2021	BUY	$444.87 - $538.88 $58.1 Million - $70.4 Million	130,572 New	130,572 $63.3 Million

Others Institutions Holding TECH

# of Institutions

649

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Bio Techne Corp Transaction History